DGX
USDQuest Diagnostics Incorporated Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$179.350
Kõrge
$180.040
Madal
$176.310
Maht
0.20M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
19.8B
Tööstusharu
Diagnostics & Research
Riik
United States
Kauplemisstatistika
Keskmine maht
0.90M
Börs
NYQ
Valuuta
USD
52 nädala vahemik
Seotud uudised
New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer's Disease Diagnosis
Two blood tests, each involving multiple biomarkers, are highly accurate at identifying Alzheimer's disease pathology in symptomatic patients,...
Barclays Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $195
Barclays analyst Stephanie Davis maintains Quest Diagnostics with a Equal-Weight and raises the price target from $190 to $195.
Truist Securities Maintains Hold on Quest Diagnostics, Raises Price Target to $205
Truist Securities analyst David Macdonald maintains Quest Diagnostics with a Hold and raises the price target from $195 to $205.
Leerink Partners Maintains Outperform on Quest Diagnostics, Raises Price Target to $210
Leerink Partners analyst Michael Cherny maintains Quest Diagnostics with a Outperform and raises the price target from $203 to $210.
Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025
Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced financial results for the third...
Evercore ISI Group Maintains In-Line on Quest Diagnostics, Raises Price Target to $190
Evercore ISI Group analyst Elizabeth Anderson maintains Quest Diagnostics with a In-Line and raises the price target from $185 to $190.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.